C B PHARMA ACQUISITION CORP
Q1 2016 13F Holders
CUSIP
G2029P134
Type
Equity
Class
RIGHT 06/17/2016
Num filings
5
Total reported value, excl. options
$111 k
Compare 2016 Q1 to
2015 Q4
2015 Q3
2015 Q2
2015 Q1
Manager
Report Date
Value ($000)
Shares
Option Type